Search 

Powered by

"The Apothecary" & Other Communications

"The Apothecary"

News Items

Health Canada Advisories

"The Apothecary"

The Apothecary Winter 2011
 
"The Apothecary" Archives

2011

2003-2004

2009-2010

2001-2002

2007-2008

2000

2005-2006

 


News Items

November 9, 2011 - NAPRA Notes Fall 2011
 
News Archives

2009-2011

2004-2006

2007-2008

2001-2003
 
Press Release Archives

2000-2008



Health Canada Advisories

Advisories from the last month are listed below.

For older advisories, please consult the appropriate archive.

 

For Health Professionals:
January 31, 2012 - VELCADEŽ (bortezomib): Fatal if Given Intrathecally  
January 30, 2012 - Association of CELEXAŽ (citalopram hydrobromide) with Dose - Dependent QT Prolongation  
January 23, 2012 - Potential risks of cardiovascular and renal adverse events in patients with type 2 diabetes treated with aliskiren (RASILEZ*) or aliskiren/hydrochlorothiazide (RASILEZ HCT*) 
December 23, 2011 - Important Safety Information on the Correct Use of EpiPenŽ and EpiPenŽ Jr Auto-Injector

For the Public:
January 30, 2012 - Association of CELEXAŽ (citalopram hydrobromide; also marketed as generics) and abnormal heart rhythms  
January 23, 2012 - Potential risks of cardiovascular and renal adverse events in patients with type 2 diabetes treated with aliskiren (RASILEZ*) or aliskiren/hydrochlorothiazide (RASILEZ HCT*) 
January 19, 2012 - Champix: Updated safety information for the smoking-cessation drug  
January 19, 2012 - Important Reminder about Weight-loss Health Products  
January 13, 2012 - Novartis Recall of Excedrin Products Extends to Canada  
 
Health Canada Advisories for Health Professionals Archives
Health Canada Advisories for the Public Archives
 
[Back to Top]
 
Newfoundland and Labrador Pharmacy Board     |     Apothecary Hall    |    488 Water Street, St. John's, NL A1E 1B3    |    Tel: 709-753-5877    Toll-Free: 1-877-453-5877    Fax: 709-753-8615
Site Map     Disclaimer